What is the Future of PSA Testing in Epidemiology?
The future of PSA testing in epidemiology may involve the development of more specific biomarkers and advanced screening techniques to improve accuracy and reduce unnecessary interventions. Research is ongoing to identify genetic and molecular markers that can complement PSA testing, providing a more comprehensive assessment of prostate cancer risk. Additionally, improved risk stratification methods may help tailor screening recommendations to individual patients, optimizing the balance between benefits and harms.
